The company had projected its earnings for the earlier quarter on the consensus expectations of $0.41, suggesting earnings growth of 52.60% y/y. Nuskin is slated to generate 15% earnings growth in 2010 having recently hiked its dividend to $0.115 per share, and upping its dividend yield to an industry-leading 1.90%. NUS also shows proficiency in terms of net profit margins, which at 6% bests the industry average of 4%. NUS' return on equity (ROE) stands at 22.50%, towering the industry average of -2%. In addition, NUS' 52-week trading range is $7.90-$28.78, while the stock is currently trading at $24.17.
Nuskin Enterprises Inc is scheduled to announce its results for the December quarter on February 4, 2010. The multi national manufacturer of anti-aging products is forecasted to post a marginal decline in earnings down to $0.40 per share.
